Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYPhase 3 Clinical Trial of Tedopi®: OSE Immunotherapeutics Announces Positive Top-Line Results for Step-1 of its trial ‘Atalante 1’ in Non-Small Cell Lung CancerPREV STORYiTeos Therapeutics Closes $125 Million Series B2 Financing